Drug ID: | NPD5345 |
Drug Name: | |
Molecular Formula: | C22H34O7 |
Canonical SMILES: | C=C[C@@]1(C)CC(=O)[C@]2([C@@](O1)(C)[C@@H](OC(=O)C)[C@H]([C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C)O)O |
Standard InCHI: | InChI=1S/C22H34O7/c1-8-19(5)11-14(25)22(27)20(6)13(24)9-10-18(3,4)16(20)15(26)17(28-12(2)23)21(22,7)29-19/h8,13,15-17,24,26-27H,1,9-11H2,2-7H3/t13-,15-,16-,17-,19-,20-,21+,22-/m0/s1 |
Standard InCHIKey: | OHCQJHSOBUTRHG-KGGHGJDLSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNC003490; DNC000461 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 47936 |
ChEBI | |
CAS Number |
Molecular Weight | 410.23 |
ALogP | -0.4347 |
MLogP | 3.11 |
XLogP | 1.43 |
HDA | 7 |
HBD | 3 |
Rotatable Bonds | 12 |
TPSA | 113.29 |
RO5 Violation | 0 |